Immunoediting of cancer metastasis by NK cells
- 1 June 2020
- journal article
- editorial
- Published by Springer Nature in Nature Cancer
- Vol. 1 (7), 670-671
- https://doi.org/10.1038/s43018-020-0081-z
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasisNature Cancer, 2020
- Control of Metastasis by NK CellsCancer Cell, 2017
- Emerging Biological Principles of MetastasisCell, 2017
- Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancerBreast Cancer Research and Treatment, 2016
- Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clustersProceedings of the National Academy of Sciences, 2016
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer MetastasisCell, 2014
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and PromotionScience, 2011
- Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancerCancer Treatment Reviews, 2009
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003